Unexo Life Sciences Private Ltd.
FDA inspection history in New Delhi, India, 2024
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2024: one warning letter and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One warning letter and one Form 483, at New Delhi, India.
Cited most
Across all Unexo Life Sciences Private observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.122Materials examination and usage criteria1
- 21 CFR 211.130Packaging and labeling operations1
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.165Testing and release for distribution1
The complete Unexo Life Sciences Private file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
New Delhi, India
One warning letter and one Form 483 · 2024 · 12 observations
Latest: Warning letter, Nov 6, 2024 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-11-06 | Warning letter Warning letter | New Delhi, India | — | $99 |
| 2024-05-14 | 483 Form 483 | New Delhi, India | 12 | $99 |
Investigators on these documents
FEI number 3013514280 · most recent document Nov 6, 2024
About Unexo Life Sciences Private Ltd.
How many FDA Form 483s has Unexo Life Sciences Private Ltd. received?
FDA Intel has 1 Form 483 on file for Unexo Life Sciences Private Ltd.; the most recent is dated May 14, 2024.
When was Unexo Life Sciences Private Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Unexo Life Sciences Private Ltd. is a Form 483 dated May 14, 2024, for the site in New Delhi, India.
What did FDA cite at Unexo Life Sciences Private Ltd.?
The regulations cited most in the observations on file for Unexo Life Sciences Private Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.122 (Materials examination and usage criteria), 1 time; 21 CFR 211.130 (Packaging and labeling operations), 1 time.
Has Unexo Life Sciences Private Ltd. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Unexo Life Sciences Private Ltd.; the most recent is dated Nov 6, 2024.